The FLRT3-UNC5B Checkpoint Pathway Inhibits T Cell–Based Cancer Immunotherapies

Using gain-of-function genetic screens, researchers profiled axon guidance proteins on human T cells and their cognate ligands and identified fibronectin leucine-rich transmembrane protein 3 (FLRT3) as a ligand that inhibits T cell activity.